Shanghai Kechow Pharma, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2014

Location

Shanghai China

Primary Industry

Pharmaceuticals

About

Based in Shanghai, China and established in 2014, Shanghai Kechow Pharma, Inc. is a biopharmaceutical company that focuses on researching and developing novel drugs for cancer. Dr. Hongqi Tian, the company's founder, chairman and chief executive officer, has more than 20 years of experience in new drug development. The company’s main business is the research and development of anti-cancer drugs. The company’s self - developed products include the anti-cancer new drug HL085, the targeted anti-cancer new drug Tuolameitini, and the HL-003 chemoradiotherapy protective agent. Its products are used in the field of cancer treatment. The company generates revenue by providing anti-cancer drugs.

Current Investors

SDIC Venture Capital, Lilly Asia Ventures, 5Y Capital

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Healthcare, Pharmaceutical Research & Development

Website

www.kechowpharma.com

Verticals

HealthTech, Research (Non-Medical)

Company Stage

Series C

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.